CS:GO: Imperial battles but loses to G2 at PGL Major Antwerp 2022

- Advertisement -

This roof Galerie standing at the edge of the cliff PGL Major Antwerp 2022 in Counter Strike: Global OffensiveCS: GO† The Brazilian team started the legends stage with a loss, then faced G2 with a 16-point loss, this time to X. Any further loss will result in elimination.

Read more

- Advertisement -

facilities

roof Galerie

  • casN
  • iron
  • fx
  • lock
  • VINIA

G2

  • Nico
  • Hunter
  • m0NESY
  • JACKZ
  • alexibi
  • XTQZZZ (coach)

Judgment: Mirage

The best start to the game was G2, which opened 6-1 in the fight against terrorism. Imperial showed they were still alive and came back well in the 7v6 showdown with fnx, iron and vini, not just 6v6. The Europeans only scored at the end of the first half and came back 8-7.

As with the first stage, the G2 was again better at gun and enemy echo. Emperors, on the other hand, were superior in the first armament, and this time they left everything the same in 10v10. After that, it was the European representatives who excelled, exchanged the carcasses well and bought the best ones. 16 to 12.

HLTV / Playback

championship

The CS:GO PGL Major Antwerp 2022 Legends Stage will take place in person in Belgium from May 14-17. In the second stage of the tournament, 16 teams, including Brazilians Imperial and FURIA, seek one of the eight Champions Stage places.

Source : The Enemy

- Advertisement -

Subscribe

Related articles

Epic offers a free game from the mafia

This time this offer for mobile players. On the web...

Battlefield 6 is faced with a big shoot, look at detailed games

The Battle Royale Card also fled in advance. Over the...

Review of Donkey Kong Bananza – destructive entertainment

Adventure for everyone. Donkey Kong returned and brought excellent innovations...

Elder Scrolls IV: Oblivion Remastered has already tried more than nine million players

The milestone was confirmed by the developers themselves. Remaster The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here